MedPath

Rural SHADE – feasibility and acceptability pilot study of an internet-delivered intervention for co-occurring depression and alcohol use in rural community residents.

Not Applicable
Conditions
Depression
Alcohol use
Mental Health - Depression
Mental Health - Addiction
Registration Number
ACTRN12612001000897
Lead Sponsor
niversity of Newcastle
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Participants will be recruited from the Australian Rural Mental Health Study (ARMHS). Participants of ARMHS are those that reside in rural or remote areas (non-Metropolitan) in New South Wales, specifically the Greater Western, Hunter New England or North Coast health regions. They were recruited to ARMHS using random selection from the electoral roll and had to reside in a house. Potential participants for the present project will be identified from the information gathered in the 3 year follow up assessment for ARMHS. Potential eligibility will be met by those with:
- elevated depressive symptoms (as indicated by a Patient Health Questionnaire-9, PHQ-9, with a score greater than 5) or current suicidal ideation (indicated by a score greater than or equal to 1 on item 9 of the PHQ-9);
and,
- Hazardous consumption of alcohol (indicated by an Alcohol Use Disorders Identification Test (AUDIT) score of >= 8) at the time of assessment; and,
- Access to telephone and internet

Exclusion Criteria

(a) any participant who does not meet the criteria for elevated depressive symptoms ; (b) people who are not using alcohol above recommended levels.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depressive symptoms as measured on the depression scale of the DASS-21.[Baseline and 10 weeks post-baseline.];Alcohol use as measured by the Time Line Follow Back.[Baseline and 10 weeks post-baseline]
Secondary Outcome Measures
NameTimeMethod
Suicidal ideation as measured by item 9 of the PHQ[Baseline and Follow up assessment (10 weeks post-baseline)];Substance use as measured by the Cannabis OTI, Amphetamine OTI and Tobacco OTI[Baseline and Follow up assessment (10 weeks post-baseline)];Caffeine use as measured through items that record daily intake of tea, coffee and caffeinated drinks.[Baseline and Follow up assessment (10 weeks post-baseline)];Computer anxiety as measured through the Computer anxiety rating scale (CARS-C Form C)[Baseline and Follow up assessment (10 weeks post-baseline)];Computer thoughts as measured by the Computer thoughts survey scale (CTS-C Form C)[Baseline and Follow up assessment (10 weeks post-baseline)];Perceptions of computer delivered treatment as measured through a qualitative interview[Follow up assessment]
© Copyright 2025. All Rights Reserved by MedPath